Athos Therapeutics CEO, Dr. Dimitrios Iliopoulos, participates in the UCLA Anderson School of Management Healthcare Conference (VITALS 2020 Conference)
Athos president & CEO is invited to participate at VITALS 2020 Conference at UCLA. Dr. Iliopoulos was invited in the “Entrepreneurship in Health Care” panel to discuss about his experience and challenges founding, funding and running a new biotech therapeutics company. The conference was organized by the Healthcare Business Association (HBA) at UCLA Anderson School […]
Athos Therapeutics Labs located in LA Biolabs Incubator in Torrance, CA
LA Biolabs (https://www.biolabs.io/la) is the premier provider of co-working space for life science start-ups with locations in all major biotechnology hubs across the U.S. Their goal is to change how scientific entrepreneurs do business by building an ecosystem that empowers them to grow quickly while also maximizing capital. BioLabs at the Lundquist Institute opened in […]
Article: Environmental triggers in IBD: a review of progress and evidence, Nature Reviews Gastroenterology & Hepatology
Read an interesting article, authored also by Athos SAB Chair, Dr. Claudio Fiocchi and Athos CEO, Dr. Dimitrios Iliopoulos, published in Nature Reviews in Gastroenterology & Hepatology (click here to see article). The article discusses about the role of different environmental factors involved in the pathogenesis of Inflammatory Bowel Diseases.